Article Information
PubMed
Print ISSN
Online ISSN
History
- Received February 22, 2005
- Accepted July 6, 2005
- Published online September 15, 2005.
Article Versions
- Earlier version (July 8, 2005 - 09:30).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Hans-Peter Gschwind,
- Ulrike Pfaar,
- Felix Waldmeier,
- Markus Zollinger,
- Claudia Sayer,
- Peter Zbinden,
- Michael Hayes,
- Rolf Pokorny,
- Michael Seiberling,
- Monique Ben-Am,
- Bin Peng and
- Gerhard Gross
- Novartis Pharma AG, Exploratory Development/Drug Metabolism & Pharmacokinetics, Basel, Switzerland (H.-P.G., U.P., F.W., M.Z., C.S., P.Z., G.G.); Novartis Pharmaceuticals Corporation, Exploratory Development/Bioanalytics & Pharmacokinetics (M.H.), Clinical Pharmacology Oncology (M.B.-A., B.P.), East Hanover, New Jersey; and Swiss Pharma Contract, Clinical Pharmacology & Clinical Research, Allschwil, Switzerland (R.P., M.S.)
- Address correspondence to:
Dr. Hans-Peter Gschwind, Exploratory Development/DMPK, Novartis Pharma AG, WKL-135.2.25, CH-4002 Basel, Switzerland. E-mail: hans-peter.gschwind{at}novartis.com